Ekaterina A. Sokolova, Alexandra S. Shadrina, Kseniya S. Sevost’ianova, Andrey I. Shevela, Evgenii Yu. Soldatsky, Evgenii I. Seliverstov, Marina Yu. Demekhova, Oleg A. Shonov, Evgenii A. Ilyukhin, Mariya A. Smetanina, Elena N. Voronina, Igor A. Zolotukhin, Maxim L. Filipenko 

Clinical and Experimental Medicine, DOI: 10.1007/s10238-015-0377-y First online: 28 September 2015 

Recently, the association of polymorphism rs1800562 (p.C282Y) in the hemochromatosis (HFE) gene with the increased risk of venous ulceration was shown. We hypothesized that HFE gene polymorphism might be involved not only in ulceration process, but also in susceptibility to primary varicose veins. We genotyped HFE p.C282Y (rs1800562) and p.H63D (rs1799945) variants in patients with primary varicose veins (n = 463) and in the control group (n = 754). In our study, p.282Y variant (rs1800562 A allele) was significantly associated with the risk of varicose veins (OR 1.79, 95 % CI = 1.11–2.89, P = 0.02). A borderline significant reverse association of p.63D variant (rs1799945 G allele) with venous leg ulcer development was revealed in Russians (OR 0.25, 95 % CI = 0.06–1.00, P = 0.05), but not in the meta-analysis (P = 0.56). We conclude that the HFE gene polymorphism can affect the risk of developing primary varicose veins.